These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18160671)

  • 1. Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.
    Xiang Z; Zhao Y; Mitaksov V; Fremont DH; Kasai Y; Molitoris A; Ries RE; Miner TL; McLellan MD; DiPersio JF; Link DC; Payton JE; Graubert TA; Watson M; Shannon W; Heath SE; Nagarajan R; Mardis ER; Wilson RK; Ley TJ; Tomasson MH
    Blood; 2008 May; 111(9):4809-12. PubMed ID: 18160671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
    Tomasson MH; Xiang Z; Walgren R; Zhao Y; Kasai Y; Miner T; Ries RE; Lubman O; Fremont DH; McLellan MD; Payton JE; Westervelt P; DiPersio JF; Link DC; Walter MJ; Graubert TA; Watson M; Baty J; Heath S; Shannon WD; Nagarajan R; Bloomfield CD; Mardis ER; Wilson RK; Ley TJ
    Blood; 2008 May; 111(9):4797-808. PubMed ID: 18270328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.
    Kameda T; Shide K; Shimoda HK; Hidaka T; Kubuki Y; Katayose K; Taniguchi Y; Sekine M; Kamiunntenn A; Maeda K; Nagata K; Matsunaga T; Shimoda K
    Int J Hematol; 2010 Sep; 92(2):320-5. PubMed ID: 20697856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
    Jeong EG; Kim MS; Nam HK; Min CK; Lee S; Chung YJ; Yoo NJ; Lee SH
    Clin Cancer Res; 2008 Jun; 14(12):3716-21. PubMed ID: 18559588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.
    Flex E; Petrangeli V; Stella L; Chiaretti S; Hornakova T; Knoops L; Ariola C; Fodale V; Clappier E; Paoloni F; Martinelli S; Fragale A; Sanchez M; Tavolaro S; Messina M; Cazzaniga G; Camera A; Pizzolo G; Tornesello A; Vignetti M; Battistini A; Cavé H; Gelb BD; Renauld JC; Biondi A; Constantinescu SN; Foà R; Tartaglia M
    J Exp Med; 2008 Apr; 205(4):751-8. PubMed ID: 18362173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
    Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
    J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
    Steensma DP; McClure RF; Karp JE; Tefferi A; Lasho TL; Powell HL; DeWald GW; Kaufmann SH
    Leukemia; 2006 Jun; 20(6):971-8. PubMed ID: 16598306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-γ.
    Gordon GM; Lambert QT; Daniel KG; Reuther GW
    Biochem J; 2010 Dec; 432(2):255-65. PubMed ID: 20868368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic and Molecular Characteristics of De Novo AML With
    Hidalgo-López JE; Kanagal-Shamanna R; Medeiros LJ; Estrov Z; Yin CC; Verstovsek S; Konoplev S; Jorgensen JL; Mohammad MM; Miranda RN; Zhao C; Lee J; Zuo Z; Bueso-Ramos CE
    J Natl Compr Canc Netw; 2017 Jun; 15(6):790-796. PubMed ID: 28596259
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia.
    Heo SG; Koh Y; Kim JK; Jung J; Kim HL; Yoon SS; Park JW
    BMC Med Genet; 2017 Mar; 18(1):23. PubMed ID: 28249600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations.
    Ren Y; Zhang Y; Liu RZ; Fenstermacher DA; Wright KL; Teer JK; Wu J
    Sci Rep; 2013 Oct; 3():3042. PubMed ID: 24154688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
    Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
    EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferon.
    Hornakova T; Chiaretti S; Lemaire MM; Foà R; Ben Abdelali R; Asnafi V; Tartaglia M; Renauld JC; Knoops L
    Blood; 2010 Apr; 115(16):3287-95. PubMed ID: 20167706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK2 V617F mutation in de novo acute myelogenous leukemias.
    Lee JW; Kim YG; Soung YH; Han KJ; Kim SY; Rhim HS; Min WS; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
    Oncogene; 2006 Mar; 25(9):1434-6. PubMed ID: 16247455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
    Chang YJ; Holtzman MJ; Chen CC
    Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia.
    Li Q; Li B; Hu L; Ning H; Jiang M; Wang D; Liu T; Zhang B; Chen H
    Oncotarget; 2017 May; 8(21):34687-34697. PubMed ID: 28410228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
    Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parafibromin Is a Component of IFN-γ-Triggered Signaling Pathways That Facilitates JAK1/2-Mediated Tyrosine Phosphorylation of STAT1.
    Wei J; Lian H; Zhong B; Shu HB
    J Immunol; 2015 Sep; 195(6):2870-8. PubMed ID: 26232434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
    Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
    Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.